Wenshu Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wenshu Ge has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Yiman Tang
Fourth Clinical Division
6 shared publicationsYong Jiang
Department of General Dentistry II, Peking University School and Hospital of Stomatology, Beijing, People’s Republic of China
3 shared publicationsXiao Zhang
Department of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing, China
2 shared publicationsYongsheng Zhou
Department of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing, China
2 shared publications- Yongsheng Zhou
Peking University School and Hospital of Stomatology
2 shared publications Cheng Cao
Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2380
Antitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models
Background/Objectives: This study evaluated the antitumor activity of a Bupleurum chinense-derived extracellular vesicle-like particle (BC-EVLP) preparation in MOC1 oral squamous cell carcinoma (OSCC) models. Methods: Fresh roots were processed by differential centrifugation, filtration, ultracentrifugation, and sucrose density-gradient separation. The preparation was characterized by transmission electron microscopy, nanoparticle tracking analysis, and total protein measurement. Cellular association, viability, ROS-associated fluorescence, mitochondrial membrane potential, and Annexin V-FITC/PI staining were assessed. Cell viability was also compared after exposure to equal added volumes of the preparation or pre-gradient ultracentrifugation supernatant. Female C57BL/6 mice bearing syngeneic MOC1 tumors received peritumoral treatment every 3 days for 14 days, followed by tumor histology. Results: The preparation contained nanoscale vesicle-like structures, with median and mean particle diameters of 162.0 and 191.9 nm. DiI-associated fluorescence was detected in MOC1 cells after 4 h. Treatment reduced cell viability and was associated with increased DCF fluorescence, a lower JC-1 red/green ratio, and increased Annexin V-positive fractions. The BC-EVLP preparation reduced cell viability more than the supernatant at equal added volumes, although the higher-volume supernatant treatment retained partial activity. High-dose treatment attenuated tumor growth in vivo, and representative tumor sections showed less densely cellular areas. Conclusions: The BC-EVLP preparation exhibited antitumor activity in the tested MOC1 models. The active constituents and the relative contributions of vesicular and non-vesicular components remain unresolved.
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2380
Open AccessAntitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models
Background/Objectives: This study evaluated the antitumor activity of a Bupleurum chinense-derived extracellular vesicle-like particle (BC-EVLP) preparation in MOC1 oral squamous cell carcinoma (OSCC) models. Methods: Fresh roots were processed by differential centrifugation, filtration, ultracentrifugation, and sucrose density-gradient separation. The preparation was characterized by transmission electron microscopy, nanoparticle tracking analysis, and total protein measurement. Cellular association, viability, ROS-associated fluorescence, mitochondrial membrane potential, and Annexin V-FITC/PI staining were assessed. Cell viability was also compared after exposure to equal added volumes of the preparation or pre-gradient ultracentrifugation supernatant. Female C57BL/6 mice bearing syngeneic MOC1 tumors received peritumoral treatment every 3 days for 14 days, followed by tumor histology. Results: The preparation contained nanoscale vesicle-like structures, with median and mean particle diameters of 162.0 and 191.9 nm. DiI-associated fluorescence was detected in MOC1 cells after 4 h. Treatment reduced cell viability and was associated with increased DCF fluorescence, a lower JC-1 red/green ratio, and increased Annexin V-positive fractions. The BC-EVLP preparation reduced cell viability more than the supernatant at equal added volumes, although the higher-volume supernatant treatment retained partial activity. High-dose treatment attenuated tumor growth in vivo, and representative tumor sections showed less densely cellular areas. Conclusions: The BC-EVLP preparation exhibited antitumor activity in the tested MOC1 models. The active constituents and the relative contributions of vesicular and non-vesicular components remain unresolved.
- Open Access
- 22 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (10) , e23664
Knockdown of LAP2α inhibits adipogenesis of human adipose‐derived stem cells and ameliorates high‐fat diet‐induced obesity
Adipogenesis, a pivotal cellular process involving the differentiation of mesenchymal stem cells (MSCs) to mature adipocytes, plays a significant role in various physiological functions. Dysregulation of adipogenesis is implicated in conditions such as obesity. However, the complete molecular understanding of adipogenesis remains elusive. This study aimed to uncover the novel role of lamina‐associated polypeptide 2 alpha (LAP2α) in human adipose‐derived stem cells (hASCs) adipogenesis and its impact on high‐fat diet (HFD)‐induced obesity and associated metabolic disturbances. LAP2α expression was assessed during the adipogenic differentiation of hASCs using RT‐qPCR and western blotting. The functional role of LAP2α in adipogenesis was explored both in vitro and in vivo through loss‐ and gain‐of‐function studies. Moreover, mice with HFD‐induced obesity received lentivirus injection to assess the effect of LAP2α knockdown on fat accumulation. Molecular mechanisms underlying LAP2α in adipogenic differentiation were investigated using RT‐qPCR, Western blotting, immunofluorescence staining, and Oil Red O staining. LAP2α expression was upregulated during hASCs adipogenic differentiation. LAP2α knockdown hindered adipogenesis, while LAP2α overexpression promoted adipogenic differentiation. Notably, LAP2α deficiency resisted HFD‐induced obesity, improved glucose intolerance, mitigated insulin resistance, and prevented fatty liver development. Mechanistically, LAP2α knockdown attenuated signal transducer and activator of transcription 3 (STAT3) activation by reducing the protein level of phosphorylated STAT3. A STAT3 activator (Colivelin) counteracted the negative impact of LAP2α deficiency on hASCs adipogenic differentiation. Taken together, our current study established LAP2α as a crucial regulator of hASCs adipogenic differentiation, unveiling a new therapeutic target for obesity prevention.
- 22 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (10) , e23664
Open AccessKnockdown of LAP2α inhibits adipogenesis of human adipose‐derived stem cells and ameliorates high‐fat diet‐induced obesity
Adipogenesis, a pivotal cellular process involving the differentiation of mesenchymal stem cells (MSCs) to mature adipocytes, plays a significant role in various physiological functions. Dysregulation of adipogenesis is implicated in conditions such as obesity. However, the complete molecular understanding of adipogenesis remains elusive. This study aimed to uncover the novel role of lamina‐associated polypeptide 2 alpha (LAP2α) in human adipose‐derived stem cells (hASCs) adipogenesis and its impact on high‐fat diet (HFD)‐induced obesity and associated metabolic disturbances. LAP2α expression was assessed during the adipogenic differentiation of hASCs using RT‐qPCR and western blotting. The functional role of LAP2α in adipogenesis was explored both in vitro and in vivo through loss‐ and gain‐of‐function studies. Moreover, mice with HFD‐induced obesity received lentivirus injection to assess the effect of LAP2α knockdown on fat accumulation. Molecular mechanisms underlying LAP2α in adipogenic differentiation were investigated using RT‐qPCR, Western blotting, immunofluorescence staining, and Oil Red O staining. LAP2α expression was upregulated during hASCs adipogenic differentiation. LAP2α knockdown hindered adipogenesis, while LAP2α overexpression promoted adipogenic differentiation. Notably, LAP2α deficiency resisted HFD‐induced obesity, improved glucose intolerance, mitigated insulin resistance, and prevented fatty liver development. Mechanistically, LAP2α knockdown attenuated signal transducer and activator of transcription 3 (STAT3) activation by reducing the protein level of phosphorylated STAT3. A STAT3 activator (Colivelin) counteracted the negative impact of LAP2α deficiency on hASCs adipogenic differentiation. Taken together, our current study established LAP2α as a crucial regulator of hASCs adipogenic differentiation, unveiling a new therapeutic target for obesity prevention.
- Open Access
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 1033223
Ubiquitin modification in osteogenic differentiation and bone formation: From mechanisms to clinical significance
The ubiquitin–proteasome system is an important pathway for mediating posttranslational modification and protein homeostasis and exerts a wide range of functions in diverse biological processes, including stem cell differentiation, DNA repair, and cell cycle regulation. Many studies have shown that ubiquitination modification plays a critical role in regulating the osteogenic differentiation of stem cells and bone formation through various mechanisms. This review summarizes current progress on the effects and mechanisms of ubiquitin modification on transcription factors and signaling pathways involved in osteogenic differentiation. Moreover, the review highlights the latest advances in the clinical application of drugs in bone tissue engineering. A thorough understanding of ubiquitin modifications may provide promising therapeutic targets for stem cell-based bone tissue engineering.
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 1033223
Open AccessUbiquitin modification in osteogenic differentiation and bone formation: From mechanisms to clinical significance
The ubiquitin–proteasome system is an important pathway for mediating posttranslational modification and protein homeostasis and exerts a wide range of functions in diverse biological processes, including stem cell differentiation, DNA repair, and cell cycle regulation. Many studies have shown that ubiquitination modification plays a critical role in regulating the osteogenic differentiation of stem cells and bone formation through various mechanisms. This review summarizes current progress on the effects and mechanisms of ubiquitin modification on transcription factors and signaling pathways involved in osteogenic differentiation. Moreover, the review highlights the latest advances in the clinical application of drugs in bone tissue engineering. A thorough understanding of ubiquitin modifications may provide promising therapeutic targets for stem cell-based bone tissue engineering.
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 101036
Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 101036
Open AccessEpithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability
- Open Access
- 1 July 2020
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-13
Knockdown of LAP2α inhibits osteogenic differentiation of human adipose-derived stem cells by activating NF-κB
Background: Lamina-associated polypeptide 2α (LAP2α) is a nucleoplasmic protein that has been involved in the regulation of the cell cycle, gene transcription, and adult stem cell function. LAP2α down-regulation is linked to age-related osteoporosis and bone deformities; however, the underlying mechanisms remain obscure. The present study aimed to elucidate the function of LAP2α in the osteogenic differentiation of human adipose-derived stem cells (hASCs), which are attractive sources for bone tissue engineering. Methods: The expression of LAP2α during the osteogenic differentiation of hASCs was detected firstly. A loss of function investigation was then carried out to characterize the function of LAP2α in osteogenic differentiation of hASCs both in vitro and in vivo. Moreover, RNA-sequences, western blotting, and confocal analyses were performed to clarify the molecular mechanism of LAP2α-regulated osteogenesis. Results: We found that LAP2α expression was upregulated upon osteogenic induction. Both in vitro and in vivo experiments indicated that LAP2α knockdown resulted in impaired osteogenic differentiation of hASCs. Mechanistically, we revealed that LAP2α deficiency activated nuclear factor kappa B (NF-κB) signaling by controlling the cytoplasmic-nuclear translocation of p65. Conclusions: Collectively, our findings revealed that LAP2α functions as an essential regulator for osteogenesis of hASCs by modulating NF-κB signaling, thus providing novel insights for mesenchymal stem cell-mediated bone tissue engineering.
- 1 July 2020
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-13
Open AccessKnockdown of LAP2α inhibits osteogenic differentiation of human adipose-derived stem cells by activating NF-κB
Background: Lamina-associated polypeptide 2α (LAP2α) is a nucleoplasmic protein that has been involved in the regulation of the cell cycle, gene transcription, and adult stem cell function. LAP2α down-regulation is linked to age-related osteoporosis and bone deformities; however, the underlying mechanisms remain obscure. The present study aimed to elucidate the function of LAP2α in the osteogenic differentiation of human adipose-derived stem cells (hASCs), which are attractive sources for bone tissue engineering. Methods: The expression of LAP2α during the osteogenic differentiation of hASCs was detected firstly. A loss of function investigation was then carried out to characterize the function of LAP2α in osteogenic differentiation of hASCs both in vitro and in vivo. Moreover, RNA-sequences, western blotting, and confocal analyses were performed to clarify the molecular mechanism of LAP2α-regulated osteogenesis. Results: We found that LAP2α expression was upregulated upon osteogenic induction. Both in vitro and in vivo experiments indicated that LAP2α knockdown resulted in impaired osteogenic differentiation of hASCs. Mechanistically, we revealed that LAP2α deficiency activated nuclear factor kappa B (NF-κB) signaling by controlling the cytoplasmic-nuclear translocation of p65. Conclusions: Collectively, our findings revealed that LAP2α functions as an essential regulator for osteogenesis of hASCs by modulating NF-κB signaling, thus providing novel insights for mesenchymal stem cell-mediated bone tissue engineering.
- Open Access
- 14 August 2017
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 8 (1) , 1-14
Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells
Human adipose-derived stem cells (hASCs) are multipotent progenitor cells with self-renewal capabilities and multilineage differentiation potential, including osteogenesis. Although protein deubiquitinases have been linked to stem cell fate determination, whether protein deubiquitination contributes to lineage commitment during osteogenic differentiation of hASCs remains to be investigated. The objective of this study was to evaluate the effects of the ubiquitin specific protease 7 (USP7) on osteogenic differentiation of hASCs. An osteocalcin promoter driven luciferase reporter system was established to initially discover the potential association between USP7 and hASC osteogenesis. To further characterize the function of USP7 in osteogenic differentiation of hASCs, a combination of in vitro and in vivo experiments were carried out through genetic depletion or overexpression of USP7 using a lentiviral strategy. Moreover, HBX 41,108, a cyanoindenopyrazine-derived deubiquitinase inhibitor of USP7, was utilized at different doses to further examine whether USP7 regulated osteogenic differentiation of hASCs through its enzymatic activity. We demonstrated that USP7 depletion was associated with remarkable downregulation of the reporter gene activity. Genetic depletion of USP7 by lentiviral RNAi markedly suppressed hASC osteogenesis both in vitro and in vivo, while overexpression of USP7 enhanced the osteogenic differentiation of hASCs. Notably, chemical blockade via the small molecular inhibitor HBX 41,108 could efficiently mimic the effects of USP7 genetic depletion in a dose-dependent manner. Taken together, our study revealed that protein deubiquitinase USP7 is an essential player in osteogenic differentiation of hASCs through its catalytic activity, and supported the pursuit of USP7 as a potential target for modulation of hASC-based stem cell therapy and bone tissue engineering.
- 14 August 2017
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 8 (1) , 1-14
Open AccessProtein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells
Human adipose-derived stem cells (hASCs) are multipotent progenitor cells with self-renewal capabilities and multilineage differentiation potential, including osteogenesis. Although protein deubiquitinases have been linked to stem cell fate determination, whether protein deubiquitination contributes to lineage commitment during osteogenic differentiation of hASCs remains to be investigated. The objective of this study was to evaluate the effects of the ubiquitin specific protease 7 (USP7) on osteogenic differentiation of hASCs. An osteocalcin promoter driven luciferase reporter system was established to initially discover the potential association between USP7 and hASC osteogenesis. To further characterize the function of USP7 in osteogenic differentiation of hASCs, a combination of in vitro and in vivo experiments were carried out through genetic depletion or overexpression of USP7 using a lentiviral strategy. Moreover, HBX 41,108, a cyanoindenopyrazine-derived deubiquitinase inhibitor of USP7, was utilized at different doses to further examine whether USP7 regulated osteogenic differentiation of hASCs through its enzymatic activity. We demonstrated that USP7 depletion was associated with remarkable downregulation of the reporter gene activity. Genetic depletion of USP7 by lentiviral RNAi markedly suppressed hASC osteogenesis both in vitro and in vivo, while overexpression of USP7 enhanced the osteogenic differentiation of hASCs. Notably, chemical blockade via the small molecular inhibitor HBX 41,108 could efficiently mimic the effects of USP7 genetic depletion in a dose-dependent manner. Taken together, our study revealed that protein deubiquitinase USP7 is an essential player in osteogenic differentiation of hASCs through its catalytic activity, and supported the pursuit of USP7 as a potential target for modulation of hASC-based stem cell therapy and bone tissue engineering.
- Open Access
- 1 August 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (31) , 12874-12884
The X-linked deubiquitinase USP9X is an integral component of centrosome
- 1 August 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (31) , 12874-12884
Open AccessThe X-linked deubiquitinase USP9X is an integral component of centrosome
- 19 July 2017
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (3) , 2366-2377
The ubiquitin ligase SCFFBXW7α promotes GATA3 degradation
GATA3 is a key transcription factor in cell fate determination and its dysregulation has been implicated in various types of malignancies. However, how the abundance and function of GATA3 are regulated remains unclear. Here, we report that GATA3 is physically associated with FBXW7α, and FBXW7α destabilizes GATA3 through assembly of a SKP1‐CUL1‐F‐box E3 ligase complex. Importantly, we showed that FBXW7α promotes GATA3 ubiquitination and degradation in a GSK3 dependent manner. Furthermore, we demonstrated that FBXW7α inhibits breast cancer cells survival through destabilizing GATA3, and the expression level of FBXW7α is negatively correlated with that of GATA3 in breast cancer samples. This study indicated that FBXW7α is a critical negative regulator of GATA3 and revealed a pathway for the maintenance of GATA3 abundance in breast cancer cells.
- 19 July 2017
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (3) , 2366-2377
The ubiquitin ligase SCFFBXW7α promotes GATA3 degradation
GATA3 is a key transcription factor in cell fate determination and its dysregulation has been implicated in various types of malignancies. However, how the abundance and function of GATA3 are regulated remains unclear. Here, we report that GATA3 is physically associated with FBXW7α, and FBXW7α destabilizes GATA3 through assembly of a SKP1‐CUL1‐F‐box E3 ligase complex. Importantly, we showed that FBXW7α promotes GATA3 ubiquitination and degradation in a GSK3 dependent manner. Furthermore, we demonstrated that FBXW7α inhibits breast cancer cells survival through destabilizing GATA3, and the expression level of FBXW7α is negatively correlated with that of GATA3 in breast cancer samples. This study indicated that FBXW7α is a critical negative regulator of GATA3 and revealed a pathway for the maintenance of GATA3 abundance in breast cancer cells.